Deshkar Sanjeevani, Yeole Purva, Mahore Jayashri, Shinde Ankita, Giram Prabhanjan
Department of Pharmaceutics, Dr. D. Y. Patil Unitech Society's, Dr. D. Y. Patil Institute of Pharmaceutical Science & Research, Pune 411018, India.
Department of Pharmaceutical Sciences, The State University of New York, Buffalo, NY 14214, USA.
Gels. 2023 Oct 27;9(11):851. doi: 10.3390/gels9110851.
Worldwide, 40 to 50% of women suffer from reproductive tract infections. Most of these infections are mixed infections, are recurrent and difficult to treat with antimicrobials or antifungals alone. For symptomatic relief of infections, oral antimicrobial therapy must be combined with topical therapy. The purpose of this work is to optimize and develop a polyelectrolyte complex (PEC) of chitosan/anion for the formulation of posaconazole- and probiotic-loaded vaginal hydrogel inserts with prolonged release and significant mucoadhesion. PECs were prepared using chitosan as cationic and carrageenan, pectin and polycarbophil as anionic polymers via a lyophilization technique. PEC formation was confirmed by scanning electron microscopy, Fourier transform infrared spectroscopy and differential scanning calorimetry, by observing changes in its surface, physical and thermal properties. The probiotic, , was added to the PEC during the lyophilization process and the effect on the probiotic viability was studied. The PECs were further compressed along with posaconazole to form hydrogel inserts and optimized using a 3 full-factorial design. The hydrogel inserts were assessed for swelling behavior, drug release, in vitro mucoadhesion and in vitro antifungal activity. The chitosan-pectin hydrogel insert demonstrated excellent mucoadhesion (1.25 N), sustained drug release (88.2 ± 2.4% in 8 h) and a swelling index of 154.7%. The efficacy of hydrogel inserts was evaluated using in vitro study with a co-culture of and . This study revealed an increase in count and a significant drop in the viable count of (4-log reduction in 24 h), indicating the effectiveness of hydrogel inserts in alleviating the fungal infection. Overall, our study demonstrated the potential of the hydrogel insert for preventing vaginal infection and restoring normal vaginal microbiota.
在全球范围内,40%至50%的女性患有生殖道感染。这些感染大多为混合感染,具有复发性,仅用抗菌药物或抗真菌药物难以治疗。为了缓解感染症状,口服抗菌治疗必须与局部治疗相结合。本研究的目的是优化并开发一种壳聚糖/阴离子聚电解质复合物(PEC),用于制备负载泊沙康唑和益生菌的阴道水凝胶插入剂,使其具有缓释和显著的粘膜粘附性。通过冻干技术,以壳聚糖为阳离子聚合物,以卡拉胶、果胶和聚卡波非为阴离子聚合物制备PEC。通过扫描电子显微镜、傅里叶变换红外光谱和差示扫描量热法观察其表面、物理和热性能的变化,证实了PEC的形成。在冻干过程中将益生菌添加到PEC中,并研究其对益生菌活力的影响。将PEC与泊沙康唑进一步压制成水凝胶插入剂,并采用三因素全因子设计进行优化。对水凝胶插入剂的溶胀行为、药物释放、体外粘膜粘附性和体外抗真菌活性进行了评估。壳聚糖-果胶水凝胶插入剂表现出优异的粘膜粘附性(1.25 N)、持续药物释放(8小时内释放88.2±2.4%)和154.7%的溶胀指数。通过与白色念珠菌和热带念珠菌共培养的体外研究评估了水凝胶插入剂的疗效。该研究显示白色念珠菌数量增加,热带念珠菌活菌数量显著下降(24小时内减少4个对数级),表明水凝胶插入剂在缓解真菌感染方面的有效性。总体而言,我们的研究证明了水凝胶插入剂在预防阴道感染和恢复正常阴道微生物群方面的潜力。